Navigation Links
CVS Caremark Issues Statement on Settlement Concerning Disposal of Patient Information at its Retail Stores
Date:2/18/2009

WOONSOCKET, R.I., Feb. 18 /PRNewswire-FirstCall/ -- CVS Caremark Corporation (NYSE: CVS) announced today that it has entered into an agreement with the U.S. Federal Trade Commission (FTC) and the U.S. Department of Health and Human Services Office for Civil Rights (OCR) concerning disposal of patient information at its retail pharmacy stores. The agreement resolves an investigation prompted by media reports from 2006 about alleged incidents of inadvertent disposal of patient information in dumpsters at a limited number of CVS/pharmacy locations in a manner that was inconsistent with the Company's waste disposal procedures.

The investigation was initiated prior to the merger between CVS and Caremark, involved CVS/pharmacy retail locations only and did not relate to the PBM business. The Company responded to these reports by promptly enhancing its retail waste disposal policies and training programs, and instituted a chain-wide shredding program for confidential waste to further guard against inadvertent disposal of confidential information in the regular trash.

CVS Caremark is not aware of any consumer harm arising out of, or related to, the alleged incidents. Per the agreement with the FTC and the OCR, the Company has expressly denied engaging in any wrongful conduct and agreed to settle the matter in order to avoid the time and expense of further legal proceedings.

CVS Caremark is committed to being an industry leader in privacy matters and places high priority on protecting the privacy of its customers and plan participants. The Company has comprehensive policies and procedures in place to safeguard personal and health information and follows federal and state laws in handling this sensitive data. CVS Caremark's settlement obligations with the FTC and the OCR reinforce existing business practices in regard to protecting patient information, employee training on privacy issues, and monitoring the effectiveness of privacy policies and procedures on a regular basis.

About CVS Caremark

CVS Caremark (NYSE: CVS) is the largest provider of prescriptions in the nation. The Company fills or manages more than 1 billion prescriptions annually. Through its unmatched breadth of service offerings, CVS Caremark is transforming the delivery of health care services in the U.S. The Company is uniquely positioned to effectively manage costs and improve health care outcomes through its more than 6,800 CVS/pharmacy and Longs Drugs stores; its Caremark Pharmacy Services division (pharmacy benefit management, mail order and specialty pharmacy); its retail-based health clinic subsidiary, MinuteClinic; and its online pharmacy, CVS.com. General information about CVS Caremark is available through the Investor Relations section of the Company's Web site, at http://cvscaremark.com/investors, as well as through the Newsroom section of the Company's Web site, at http://cvscaremark.com/newsroom.

CONTACTS

Media: Eileen Howard Dunn, 401-770-4561

Investors: Nancy Christal, 401-770-3614


'/>"/>
SOURCE CVS Caremark Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Caremark Customer Care Centers Recognized for Customer Satisfaction Excellence by J.D. Power and Associates Certified Call Center Program(SM)
2. CVS Caremark Presents Influenza Vaccine Data at Rescheduled 2008 DMAA Annual Meeting
3. CVS Caremark Named Finalist in URAC Annual Best Practices in Health Care Consumer Empowerment and Protection Awards
4. CVS Caremark Applauds FTCs Leadership on Follow-on Biologics
5. CVS Caremark All Kids Can Announces the Opening of a Boundless Playground in Los Angeles to Serve Children of All Abilities
6. CVS Caremark Names Troyen Brennan, MD, EVP, Chief Medical Officer
7. SilverScript Insurance Company, a CVS Caremark Company, Provides Variety of Medicare Prescription Drug Plan Options for 2009
8. CVS Caremark Partners with Google Health to Provide Consumers with Online Access to their Prescription History through Caremark.com
9. CVS Caremark Reports Record Second Quarter Revenues, Operating Profit, and Earnings
10. CVS Caremark Employees Raise $1 Million and Increase Awareness for Children with Disabilities through Easter Seals Walk With Me Events Nationwide
11. CVS Caremark to Present Insights on Redefining the Consumer Health Care Experience at AHIP Institute 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... The world-class ... support to bring their novel lifesaving device for the everyday use of parents ... sensors, specially designed to read a child’s vital signs, and detect unusual symptoms ...
(Date:4/24/2017)... Ill., and Waycross, Ga. (PRWEB) , ... April ... ... market leader and trusted advisor within the telehealth industry, announces the company’s VideoMedicine ... U.S. board-certified primary care providers. Available 24 hours a day, Quick Care provides ...
(Date:4/24/2017)... ... April 24, 2017 , ... According ... overdose deaths now claim the lives of 62 Americans each day.(1) Yet since ... drug manufacturers, distributors, pharmacies and prescribers by more than half.(2) Novus Medical ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... recognize elevated anxiety levels in people with addiction who are served by MAP’s ... a biosensing wearable device that monitors heart and breath rates to identify anxiety ...
(Date:4/24/2017)... ... 2017 , ... Pitavastatin, a relatively new statin, has relevance ... to have significant interactions with antiretroviral therapy (ART). Among people living with ... inflammation in the bloodstream. , While lowering cholesterol and dampening inflammation are beneficial ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)...  IRIDEX Corporation (Nasdaq: IRIX ) today ... first quarter 2017 after the close of trading on ... host a corresponding conference call beginning at 2:30 p.m. ... in listening to the conference call may do so ... 326-3030 for international callers, using conference ID: 92158987.  A ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
Breaking Medicine Technology: